PRESS RELEASE published on 12/15/2025 at 08:00, 1 month 19 days ago STMicroelectronics and SpaceX celebrate a decade-long partnership key to Starlink global connectivity STMicroelectronics and SpaceX mark a decade-long partnership enabling global Starlink connectivity with custom-made chips and high-performing antennas. Collaboration focuses on next-gen solutions Partnership Connectivity STMicroelectronics SpaceX Starlink
PRESS RELEASE published on 12/15/2025 at 07:30, 1 month 19 days ago Appointment of François Michel as Chief Executive Officer of the GTT Group GTT Group appoints François Michel as Chief Executive Officer, effective January 5, 2026, emphasizing strategic vision and technological expertise Technology Strategic Vision Chief Executive Officer GTT Group François Michel
PRESS RELEASE published on 12/15/2025 at 07:30, 1 month 19 days ago Nomination de François Michel en qualité de Directeur général du groupe GTT Nomination de François Michel en qualité de Directeur général du groupe GTT. François Michel, expert en technologie et stratégie, prendra ses fonctions le 5 janvier 2026 pour renforcer l'innovation et la diversification de GTT Innovation Nomination Directeur Général GTT François Michel
PRESS RELEASE published on 12/15/2025 at 07:05, 1 month 19 days ago Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score Piramal Pharma Solutions achieves impressive Net Promoter Score (NPS) of 55, surpassing industry averages, reflecting commitment to excellence and stakeholder centricity Operational Excellence Net Promoter Score Piramal Pharma Solutions NPS Stakeholder Centricity
PRESS RELEASE published on 12/15/2025 at 07:05, 1 month 19 days ago Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
PRESS RELEASE published on 12/15/2025 at 07:05, 1 month 19 days ago Communiqué de presse : Sanofi fait le point sur le tolébrutinib dans la sclérose en plaques primaire progressive Sanofi annonce l'arrêt du développement du tolebrutinib dans la sclérose en plaques primaire progressive après l'étude de phase 3 PERSEUS. Profil de sécurité cohérent, analyse détaillée à venir Sclérose En Plaques Sanofi Étude Tolebrutinib PERSEUS
PRESS RELEASE published on 12/15/2025 at 07:00, 1 month 19 days ago Swiss Life: change on the Board of Directors in the coming year Swiss Life announces changes on the Board of Directors for the upcoming year, with Henry Peter and Adrienne Corboud Fumagalli stepping down, and Luisa Delgado and Patrick Frost joining Board Of Directors Swiss Life Patrick Frost Henry Peter Adrienne Corboud Fumagalli
PRESS RELEASE published on 12/15/2025 at 07:00, 1 month 19 days ago Swiss Life: changement au conseil d’administration l’année prochaine Changement au conseil d'administration de Swiss Life: Henry Peter et Adrienne Corboud Fumagalli ne seront pas réélus en 2026, Luisa Delgado et Patrick Frost les remplaceront Conseil D'administration Nominations Election Swiss Life Entreprise
PRESS RELEASE published on 12/15/2025 at 07:00, 1 month 19 days ago HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma HBM Healthcare Investments sells majority stake in Swixx Biopharma to SK Capital Partners, creating value and boosting NAV per share by 5% Healthcare Sector HBM Healthcare Investments Investment Agreement Swixx BioPharma SK Capital Partners
PRESS RELEASE published on 12/15/2025 at 07:00, 1 month 19 days ago Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics Relief Therapeutics and NeuroX complete business combination forming MindMaze Therapeutics. Newly integrated entity aims to redefine neurological care with digital treatments and AI-powered solutions Business Combination Relief Therapeutics NeuroX MindMaze Therapeutics Neurological Care
Published on 02/03/2026 at 11:30, 27 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Dr. Christoph Themel as Partner
Published on 02/03/2026 at 09:01, 2 hours 56 minutes ago Star Copper Completes Copperline Field Program with Drill Permit Submitted for 2026
Published on 02/02/2026 at 23:55, 12 hours 2 minutes ago 2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 12 hours 2 minutes ago 55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 12 hours 32 minutes ago Western Announces Sale of GlassMasters Investment
Published on 02/03/2026 at 11:15, 41 minutes ago EQS-Adhoc: hGears AG Group: Preliminary revenue and adjusted EBITDA for 2025 slightly above Management’s guidance; free cash flow affected by reclassification effect
Published on 02/03/2026 at 11:05, 52 minutes ago 2026 International AI Safety Report Charts Rapid Changes and Emerging Risks
Published on 02/03/2026 at 10:05, 1 hour 51 minutes ago Home and Kitchenware Brand Karaca Expands in Germany
Published on 02/03/2026 at 08:30, 3 hours 27 minutes ago cegedim.cloud lance la nouvelle version d’Enercare, son module de calcul et de pilotage de l’empreinte carbone
Published on 02/03/2026 at 08:00, 3 hours 57 minutes ago EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 3 hours 57 minutes ago EURAZEO ET PANTHEON METTENT EN PLACE UN VÉHICULE DE CONTINUATION DE DETTE PRIVÉE DE PRÈS DE €500 MILLIONS
Published on 02/03/2026 at 08:00, 3 hours 57 minutes ago Neoen lance la construction de trois nouveaux parcs solaires en France pour une capacité totale de 230 MWc
Published on 02/03/2026 at 08:00, 3 hours 57 minutes ago Neoen launches three new solar farms in France with a total capacity of 230 MWp